PDP1 related ferroptosis risk signature indicates distinct immune microenvironment and prognosis of breast cancer patients

ObjectiveWe aim to construct a RiskScore model to aid in the early prognosis of breast cancer (BC).MethodsBC mRNA expression profiles were obtained from TCGA and GEO databases. Differential gene expression analysis identifies PDP1-ferroptosis-related genes. LASSO Cox regression was utilized to scree...

Full description

Saved in:
Bibliographic Details
Main Authors: Yufeng Wang, Huifen Dang, Gongjian Zhu, Yingxia Tian
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1551325/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850201199602565120
author Yufeng Wang
Huifen Dang
Gongjian Zhu
Yingxia Tian
author_facet Yufeng Wang
Huifen Dang
Gongjian Zhu
Yingxia Tian
author_sort Yufeng Wang
collection DOAJ
description ObjectiveWe aim to construct a RiskScore model to aid in the early prognosis of breast cancer (BC).MethodsBC mRNA expression profiles were obtained from TCGA and GEO databases. Differential gene expression analysis identifies PDP1-ferroptosis-related genes. LASSO Cox regression was utilized to screen genes to build a RiskScore model, and survival analysis were performed to investigate the reliability in BC prognosis. Immune cell infiltration proportions were calculated using CIBERSORT and xCell algorithms. Single-cell data processing and analysis were conducted using “Seurat”, “monocle”, and “iTALK” packages. PDP1 was silenced to validate its influence on the target genes.ResultsData from public databases revealed significant upregulation of PDP1 in BC samples compared to normal tissues. A RiskScore model based on PDP1-related differential ferroptosis-related genes (FRGs) ACSL1, BNIP3, and EMC2 was developed, which effectively predicted BC patient prognosis. High-risk BC samples exhibited poorer overall survival and were associated with immune microenvironment. The model remained significant in multivariate Cox regression analysis, indicating that it could independently predict the survival of BC patients. ACSL1, BNIP3, and EMC2 were downregulated after knockdown of PDP1.ConclusionRiskScore model constructed by PDP1-ferroptosis-related genes ACSL1, BNIP3, and EMC2 is able to help predict the prognosis of BC patients.
format Article
id doaj-art-ccc3d346956245639be0f6f6bc2cd80d
institution OA Journals
issn 1663-9812
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-ccc3d346956245639be0f6f6bc2cd80d2025-08-20T02:12:06ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-04-011610.3389/fphar.2025.15513251551325PDP1 related ferroptosis risk signature indicates distinct immune microenvironment and prognosis of breast cancer patientsYufeng Wang0Huifen Dang1Gongjian Zhu2Yingxia Tian3Department of Breast Medical Oncology, Affiliated Cancer Hospital of Sun Yat-sen University, Gansu Hospital, Lanzhou, Gansu, ChinaDepartment of Breast Medical Oncology, Affiliated Cancer Hospital of Sun Yat-sen University, Gansu Hospital, Lanzhou, Gansu, ChinaDepartment of Science and Education Section, Affiliated Cancer Hospital of Sun Yat-sen University, Gansu Hospital, Lanzhou, Gansu, ChinaDepartment of Breast Medical Oncology, Affiliated Cancer Hospital of Sun Yat-sen University, Gansu Hospital, Lanzhou, Gansu, ChinaObjectiveWe aim to construct a RiskScore model to aid in the early prognosis of breast cancer (BC).MethodsBC mRNA expression profiles were obtained from TCGA and GEO databases. Differential gene expression analysis identifies PDP1-ferroptosis-related genes. LASSO Cox regression was utilized to screen genes to build a RiskScore model, and survival analysis were performed to investigate the reliability in BC prognosis. Immune cell infiltration proportions were calculated using CIBERSORT and xCell algorithms. Single-cell data processing and analysis were conducted using “Seurat”, “monocle”, and “iTALK” packages. PDP1 was silenced to validate its influence on the target genes.ResultsData from public databases revealed significant upregulation of PDP1 in BC samples compared to normal tissues. A RiskScore model based on PDP1-related differential ferroptosis-related genes (FRGs) ACSL1, BNIP3, and EMC2 was developed, which effectively predicted BC patient prognosis. High-risk BC samples exhibited poorer overall survival and were associated with immune microenvironment. The model remained significant in multivariate Cox regression analysis, indicating that it could independently predict the survival of BC patients. ACSL1, BNIP3, and EMC2 were downregulated after knockdown of PDP1.ConclusionRiskScore model constructed by PDP1-ferroptosis-related genes ACSL1, BNIP3, and EMC2 is able to help predict the prognosis of BC patients.https://www.frontiersin.org/articles/10.3389/fphar.2025.1551325/fullbreast cancerLASSO-cox regression analysisprognosisPDP1ACSL1BNIP3
spellingShingle Yufeng Wang
Huifen Dang
Gongjian Zhu
Yingxia Tian
PDP1 related ferroptosis risk signature indicates distinct immune microenvironment and prognosis of breast cancer patients
Frontiers in Pharmacology
breast cancer
LASSO-cox regression analysis
prognosis
PDP1
ACSL1
BNIP3
title PDP1 related ferroptosis risk signature indicates distinct immune microenvironment and prognosis of breast cancer patients
title_full PDP1 related ferroptosis risk signature indicates distinct immune microenvironment and prognosis of breast cancer patients
title_fullStr PDP1 related ferroptosis risk signature indicates distinct immune microenvironment and prognosis of breast cancer patients
title_full_unstemmed PDP1 related ferroptosis risk signature indicates distinct immune microenvironment and prognosis of breast cancer patients
title_short PDP1 related ferroptosis risk signature indicates distinct immune microenvironment and prognosis of breast cancer patients
title_sort pdp1 related ferroptosis risk signature indicates distinct immune microenvironment and prognosis of breast cancer patients
topic breast cancer
LASSO-cox regression analysis
prognosis
PDP1
ACSL1
BNIP3
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1551325/full
work_keys_str_mv AT yufengwang pdp1relatedferroptosisrisksignatureindicatesdistinctimmunemicroenvironmentandprognosisofbreastcancerpatients
AT huifendang pdp1relatedferroptosisrisksignatureindicatesdistinctimmunemicroenvironmentandprognosisofbreastcancerpatients
AT gongjianzhu pdp1relatedferroptosisrisksignatureindicatesdistinctimmunemicroenvironmentandprognosisofbreastcancerpatients
AT yingxiatian pdp1relatedferroptosisrisksignatureindicatesdistinctimmunemicroenvironmentandprognosisofbreastcancerpatients